ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1993-01-09
- Employees
- 831
- Market Cap
- -
- Website
- www.conbapharm.com
- Introduction
The company was formerly known as Lanxi Yunshan Pharmaceutical Factory. After more than 50 years of development, it has now grown into the largest traditional Chinese medicine enterprise in the province integrating drug research and development, production and sales. It ranks among the top 10 Chinese medicine enterprises in China, and has been selected as a “model enterprise for scientific reform” of state-owned enterprises under the State Council. The company is mainly engaged in R&D, manufacturing and sales of pharmaceuticals, Chinese medicine tablets and health products. The company's main products are “Qianlekang” brand Puleam tablets and capsules, “Tianbaoning” brand ginkgo biloba preparations, “Kangenbei” brand enteritis, “Jinaokang” brand omeprazole products, “Golden Dipper” brand compound houttuynia cordata, “Jinkang Speed” brand acetylcysteine effervescent tablets, “Zhixincang” brand musk cysteine effervescent tablets, “Kangenbei”, “Baozhilin”, “Yangtang” brand health camp series Food and functional foods. Corporate honors: Hu Jiqiang won the “Global Zhejiang Merchants Gold Award”, the 11th China Main Board Listed Company Top 100 Value Gold Award, the Zhejiang Red Cross Fraternity Merit Gold Award, 2016 Advanced Unit for the Integration of “Two Modernizations”, and the 2017 China Top 500 Brands Ranking, Conn Bell ranked 312th.
Clinical Trials
0
Trial Phases
0 Phases
Drug Approvals
103
Drug Approvals
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20253897
- Approval Date
- Apr 15, 2025
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20253896
- Approval Date
- Apr 15, 2025
Compound Dyclonine Hydrochloride and Monthal Solution
- Product Name
- 复方达克罗宁薄荷溶液
- Approval Number
- 国药准字H33022133
- Approval Date
- Sep 3, 2024
Atomoxetine Hydrochloride Oral Solution
- Product Name
- 盐酸托莫西汀口服溶液
- Approval Number
- 国药准字H20244163
- Approval Date
- Jun 28, 2024
Risperidone Oral Solution
- Product Name
- 利培酮口服液
- Approval Number
- 国药准字H20233562
- Approval Date
- May 19, 2023
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next